Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N6QB
|
||||
Former ID |
DIB000438
|
||||
Drug Name |
MT-112
|
||||
Synonyms |
BiTE antibody (solid tumor), Micromet/Bayer
|
||||
Drug Type |
Antibody
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 1 | [549000] | ||
Company |
Amgenl; bayer healthcare pharmaceuticals
|
||||
Target and Pathway | |||||
Target(s) | Glutamate carboxypeptidase II | Target Info | [543445] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
TNFalpha Signaling Pathway | |||||
WikiPathways | One Carbon Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.